Back to results
US 12,552,812 B2Granted
Pyridone multiple-membered ring derivatives and use thereof
AssigneePhaeno Therapeutics Co., Ltd.
InventorsKevin X Chen, Jian Xiong, Jingjing Wang, Guoping Hu, Jinxin Liu, Yu Han, Jian Li, Shuhui Chen
Life of this patent
Estimating the term…
Abstract
Provided are a class of pyridone multiple-membered ring derivatives and the use thereof. Specifically provided are a compound as represented by formula (VI) and a pharmaceutically acceptable salt thereof.
Claims20
A compound of formula (VI) or a pharmaceutically acceptable salt thereof,
- wherein
- R7 is selected from H and
- R8 is selected from C1-3 alkyl and
- and the C1-3 alkyl and
- are optionally substituted by 1, 2, or 3 Ra;
- R9 is selected from H, E1 is selected from Se, X1 is selected from CR10R11, and R10 and R11 together with the atom to which they are commonly connected form a C3-5 cycloalkyl group;
- alternatively, X1 and R9 together with the atom to which they are connected form
- p is selected from 0 and 1, one of E1 and E2 is selected from Se, and the other is selected from S and O;
- each R12 is independently selected from H, F, Cl, Br, I, OH, NH2, —COOH, C1-3 alkyl, C1-3 alkoxy, and C1-3 alkylamino, and the C1-3 alkyl, C1-3 alkoxy, and C1-3 alkylamino are independently substituted by 1, 2, or 3 Rb;
- T1, T2, T3, and T4 are each independently selected from CH and N;
- q is selected from 0 and 1;
- t is selected from 0, 1, 2, 3, and 4;
- each Ra and Rb is independently selected from H, F, Cl, Br, and I;
- provided that when T1 is selected from CH, E1 is selected from Se, E2 is selected from O, p is selected from 1, and q is selected from 1, each R12 is independently selected from OH and NH2.
11 more elements
A compound of the following formula or a pharmaceutically acceptable salt thereof, selected from
Dependencies are inferred from the claim text.